Dacula, Abdul D.
HRN: 24-07-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/09/2023
11/16/2023
IV
500 Mg
Q8h
Small Bowel Obstruction
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes